94 related articles for article (PubMed ID: 14598067)
1. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease.
Ceravolo R; Volterrani D; Gambaccini G; Rossi C; Logi C; Manca G; Berti C; Mariani G; Murri L; Bonuccelli U
Neurol Sci; 2003 Oct; 24(3):162-3. PubMed ID: 14598067
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
3. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.
Shimizu S; Hanyu H; Kanetaka H; Iwamoto T; Koizumi K; Abe K
Dement Geriatr Cogn Disord; 2005; 20(1):25-30. PubMed ID: 15832032
[TBL] [Abstract][Full Text] [Related]
5. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
Ceravolo R; Volterrani D; Gambaccini G; Bernardini S; Rossi C; Logi C; Tognoni G; Manca G; Mariani G; Bonuccelli U; Murri L
J Neural Transm (Vienna); 2004 Aug; 111(8):1065-73. PubMed ID: 15254794
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Lewy body dementias from Alzheimer's disease.
Tarawneh R; Galvin JE
Expert Rev Neurother; 2007 Nov; 7(11):1499-516. PubMed ID: 17997699
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
[TBL] [Abstract][Full Text] [Related]
10. Cortical rhythms reactivity in AD, LBD and normal subjects: a quantitative MEG study.
Franciotti R; Iacono D; Della Penna S; Pizzella V; Torquati K; Onofrj M; Romani GL
Neurobiol Aging; 2006 Aug; 27(8):1100-9. PubMed ID: 16076512
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging as a diagnostic tool in dementia with Lewy bodies.
Small GW
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():25-31. PubMed ID: 14676466
[TBL] [Abstract][Full Text] [Related]
12. Lewy bodies and progressive dementia: a critical review and meta-analysis.
Cercy SP; Bylsma FW
J Int Neuropsychol Soc; 1997 Mar; 3(2):179-94. PubMed ID: 9126859
[TBL] [Abstract][Full Text] [Related]
13. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
14. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
[TBL] [Abstract][Full Text] [Related]
15. Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer's disease in the early stage.
Guidi M; Paciaroni L; Paolini S; De Padova S; Scarpino O
J Neurol Sci; 2006 Oct; 248(1-2):120-3. PubMed ID: 16784757
[TBL] [Abstract][Full Text] [Related]
16. Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
Costa DC; Walker Z; Walker RW; Fontes FR
Mov Disord; 2003 Oct; 18 Suppl 7():S34-8. PubMed ID: 14531044
[TBL] [Abstract][Full Text] [Related]
17. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
Vaamonde J; Ibáñez R; García AM; Poblete V
Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter binding in chronic manganese intoxication.
Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
[TBL] [Abstract][Full Text] [Related]
19. Is there a typical pattern of brain SPECT imaging in Alzheimer's disease?
Steinling M; Defebvre L; Duhamel A; Lecouffe P; Lavenu I; Pasquier F; Charpentier P
Dement Geriatr Cogn Disord; 2001; 12(6):371-8. PubMed ID: 11598308
[TBL] [Abstract][Full Text] [Related]
20. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
